Panacea Biotec Ltd Share Price
(PANACEABIO)
₹563.85▲4.93%
as on 04:01PM, 29 Apr 2025
Panacea Biotec Performance
Day's Low
Day's High
₹542Day's Price Range₹564.252 Week's Low
52 Week's High
₹112.3552-Week Price Range₹564.2
| Returns % | |
| 1 Month Return | + 24.7 % |
| 3 Month Return | + 73.31 % |
| 1 Year Return | + 298.76 % |
| Market Stats | |
| Previous Close | ₹537.35 |
| Open | ₹542.00 |
| Volume | 2.84L |
| Upper Circuit | ₹564.20 |
| Lower Circuit | ₹510.50 |
| Market Cap | ₹3,453.62Cr |
Panacea Biotec Fundamentals
P/E Ratio
-430.42
PEG Ratio
-662.18
Market Cap
₹3,453.62 Cr
P/B Ratio
2.42
EPS
-0.25
Dividend Yield
0Sector
Pharmaceuticals
ROE
0.86
Key events for Panacea Biotec Ltd
Panacea Biotec Secures Major UNICEF Vaccine Orders - 24 Apr, 2025
Panacea Biotec received a $5.2 million order from UNICEF for 40 million doses of its bivalent oral polio vaccine, boosting shares to hit upper circuit. The company also reported improved financial performance, turning a net loss into profit. Overall, the stock is trading near its all-time high.Panacea Biotec Announces Key Management Changes - 01 Apr, 2025
Panacea Biotec Limited reported the superannuation of Associate Director Sunil Anand and the completion of Director Narotam Kumar Juneja's tenure, indicating significant leadership transitions within the company.Panacea Biotec Announces Departure of Independent Director - 30 Mar, 2025
Panacea Biotec Limited announced the completion of Mrs. Manjula Upadhyay's tenure as an Independent Director, effective March 29, 2025. The company expressed gratitude for her contributions during her term.Panacea Biotec Reports Strong Growth and Profitability - 26 Mar, 2025
Panacea Biotec has shown impressive performance with a 172% stock return over the past year. In Q3 FY25, revenue grew by 8.63% to ₹163.49 crore, and net profit reached ₹4.52 crore, indicating a turnaround. The company's focus on R&D and vaccine development enhances its position in the healthcare sector.
Insights on Panacea Biotec Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 3 months, PANACEABIO stock has moved up by 69.9%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 122.26 Cr → 169.88 Cr (in ₹), with an average increase of 15.0% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.38% to 1.16% in Mar 2025 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 4.8 Cr → 4.52 Cr (in ₹), with an average decrease of 5.8% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 72.49% to 72.48% in Mar 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 25.97% to 24.86% in Mar 2025 quarter
Panacea Biotec Financials
Panacea Biotec Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 72.48% | 0.00 | |
| Foreign Institutions | 1.16% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 24.86% | 0.00 | |
| Others | 1.49% | 0.00 |
Panacea Biotec Key Indicators
Panacea Biotec Valuation
Panacea Biotec in the last 5 years
Lowest (-915.62x)
April 25, 2024
Today (-430.42x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (113.15x)
October 5, 2023
Panacea Biotec Earnings and Dividends
Panacea Biotec Ltd Earnings Results
Panacea Biotec Ltd’s net profit jumped 298.25% since last year same period to ₹4.52Cr in the Q3 2024-2025. On a quarterly growth basis, Panacea Biotec Ltd has generated -5.83% fall in its net profits since last 3-months.
Read More about Earnings Results
Panacea Biotec Technicals Summary
Bearish
Neutral
Bullish
Panacea Biotec Ltd is currently in a Bullish trading position according to technical analysis indicators.
Panacea Biotec Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹3,453.62 Cr | 51.3% | 0.65 | -₹2 Cr | ₹559 Cr | |
| NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
| NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
| NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
| NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA |
About Panacea Biotec
Revenue: ₹163.49Cr as on December 2024 (Q4 24)
Net Profit: ₹4.44Cr as on December 2024 (Q4 24)
Listing date: 17 Apr, 1996
Chairperson Name: Rajesh Jain
| Organisation | Panacea Biotec |
| Headquarters | New Delhi |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Panacea Biotec Ltd
What is Panacea Biotec Ltd price today?
Panacea Biotec Ltd share price today stands at ₹563.85, Open: ₹542, Previous Close: ₹537.35, High: ₹564.2, Low: ₹542, 52 Week High: ₹564.2, 52 Week Low: ₹112.35.
How to Buy Panacea Biotec Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Panacea Biotec Ltd shares
What are today's traded volumes of Panacea Biotec Ltd?
Today's traded volume of Panacea Biotec Ltd(PANACEABIO) is 2.84L.
What is today's market capitalisation of Panacea Biotec Ltd?
Today's market capitalisation of Panacea Biotec Ltd(PANACEABIO) is ₹3453.62Cr.
What is the 52 Week High and Low Range of Panacea Biotec Ltd?
How much percentage Panacea Biotec Ltd is down from its 52 Week High?
Panacea Biotec Ltd (PANACEABIO) share price is ₹563.85. It is down -0.06% from its 52 Week High price of ₹564.2
How much percentage Panacea Biotec Ltd is up from its 52 Week low?
Panacea Biotec Ltd (PANACEABIO) share price is ₹563.85. It is up 401.87% from its 52 Week Low price of ₹112.35